Federation Des Caisses Desjardins Du Quebec Vascular Biogenics Ltd. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 14, 2024
SELL
$0.0 - $0.27 $0 - $1,080
-4,000 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$1.15 - $1.97 $4,600 - $7,880
4,000 New
4,000 $6.76 Million
Q2 2021

Aug 30, 2024
BUY
$1.69 - $2.67 $6,760 - $10,680
4,000 New
4,000 $9.56 Million
Q4 2018

Aug 30, 2024
BUY
$0.6 - $1.72 $2,400 - $6,880
4,000 New
4,000 $3.88 Million
Q2 2018

Aug 30, 2024
BUY
$2.05 - $3.0 $4,100 - $6,000
2,000 Added 100.0%
4,000 $8.8 Million
Q1 2017

Aug 30, 2024
BUY
N/A
2,000
2,000 $11 Million

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email